Corrigendum: genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.The Journal of clinical investigation · 2020
   Trial
2. Update Breast Cancer 2023 Part 1 - Early Stage Breast Cancer.Geburtshilfe und Frauenheilkunde · 2023
   Article
3. Extracellular matrix stiffness activates mechanosensitive signals but limits breast cancer cell spheroid proliferation and invasion.Frontiers in cell and developmental biology · 2023
   Article
4. Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.Cancer medicine · 2017
   Observational

Corrections and comments

• Erratum for
  Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.2014

Authors and funding

45 authors.

Funding

Abstract

PubMed holds no abstract for this paper.